SCHEMBL6579564

SCHEMBL6579564

O=C(c1ccc2ccccc2c1)c1nccn1CC(CCO)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
AKT1 P31749 5/20 0.35
CDK2 P24941 1/20 0.35
HTT P42858 1/20 0.34
SSTR3 P32745 1/20 0.34
TACR2 P21452 4/20 0.33
CCR3 P51677 1/20 0.33
UTS2R Q9UKP6 2/20 0.33
S1PR2 O95136 1/20 0.33
S1PR4 O95977 1/20 0.33
S1PR3 Q99500 1/20 0.33
ENPP3 O14638 1/20 0.33
ALPL P05186 1/20 0.33
XIAP P98170 1/20 0.33
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6581521 0.88 UTS2R (0.38) NPC1ALDH1A1RAB9AKMT2ASMN1; SMN2
SCHEMBL6579685 0.83 HTT (0.34) KMT2AHTTTACR2S1PR2S1PR4
SCHEMBL6579701 0.81 MCHR1 (0.35) TACR2
SCHEMBL6579045 0.80 RORC (0.41) TACR2
SCHEMBL6579784 0.80 ESRRA (0.38) KMT2ATACR2
SCHEMBL6579463 0.76 TACR2 (0.33) ALDH1A1SMN1; SMN2TACR2
SCHEMBL6577365 0.76 TACR2 (0.33) ALDH1A1SMN1; SMN2TACR2
SCHEMBL8142664 0.76 TACR2 (0.33) ALDH1A1SMN1; SMN2TACR2
SCHEMBL6158768 0.74 CA12 (0.42) HTTTACR2
SCHEMBL6579767 0.72 TDP1 (0.32) ALDH1A1KMT2AHTTTACR2S1PR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994876-B1 QUATERNARY AMMONIUM COMPOUNDS AS TACHYKININ ANTAGONISTS PFIZER LTD (GB) 2004-09-08 EP disclosed
US-6380396-B1 CHEMICAL INTERMEDIATES FOR ANTIINFLAMMATORY AGENTS PFIZER INC. 2002-04-30 US disclosed
US-6207678-B1 USED FOR TREATING INFLAMMATORY DISEASE SUCH AS ARTHRITIS, PSORIASIS, ASTHMA OR INFLAMMATORY BOWEL DISEASE, CENTRAL NERVOUS SYSTEM DISORDER SUCH AS ANXIETY, DEPRESSION, DEMENTIA OR PSYCHOSIS, GASTROINTESTINAL DISORDERS PFIZER INC 2001-03-27 US disclosed
EP-0994876-A1 QUATERNARY AMMONIUM COMPOUNDS AS TACHYKININ ANTAGONISTS Pfizer Limited (GB) 2000-04-26 EP disclosed
WO-1998057972-A1 QUATERNARY AMMONIUM COMPOUNDS AS TACHYKININ ANTAGONISTS PFIZER LIMITED (GB) 1998-12-23 WO disclosed